Oncologic outcomes in myxofibrosarcomas: the role of a multidisciplinary approach and surgical resection margins
ANZ Journal of Surgery · 2023-03 · 93 (3) · 577-584
DOI: 10.1111/ans.18320 ↗At a glance
Journal article in ANZ Journal of Surgery, published online on 2023-02-11. Written by Isaac Rhee and 9 co-authors. Institution: Department of Orthopaedics, St Vincent's Hospital, Melbourne, Victoria, Australia. Major MEDLINE topics: Fibrosarcoma, Sarcoma, Histiocytoma, Malignant Fibrous, Soft Tissue Neoplasms. Cited 12 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Backgrounds Myxofibrosarcomas (MFS) are malignant soft tissue sarcomas with an infiltrative growth pattern and propensity for local recurrence(LR).We aimed to assess our management of MFS and make recommendations about the role of a multidisciplinary team approach and margin widths.
Methods
Fifty‐seven patients were identified with MFS treated at a single sarcoma centre between 1998 and 2020. Patients were stratified based on whether they presented for a planned resection (59.6%) or after an unplanned resection (40.4%) performed at a non‐specialized facility. All patients underwent radiotherapy before definitive surgery.
Results
73.7% underwent a combined onco‐plastic approach. The 5 year LRFS rate was 78.2% (84.4%, planned, versus 70.1%, unplanned, P = 0.194) and found comparable oncological outcomes between the planned and unplanned groups for the 5 year metastasis free survival (74.5% versus 86.1%, P = 0.257), disease free survival (70.1% versus 72.4%, P = 0.677), and Overall Survival (64.5% versus 75.9%, P = 0.950). Margin width ≥ 2 cm was obtained in 84.2% of cases and improved local control (HR = 0.22; 95% CI 0.06–0.81; P = 0.023), metastasis (HR = 0.24; 95% CI 0.07–0.80; P = 0.019) and mortality rates (HR = 0.23; 95% CI 0.09, 0.61; P = 0.003) compared to 3 cm did not further affect oncological outcomes.
Conclusion
Our study shows that a multidisciplinary team approach allows the achievement of low local recurrence rate and good oncological outcomes of myxofibrosarcomas, regardless of presentation status. We recommend a minimum of 2 cm margin width.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Orthopaedics, St Vincent's Hospital, Melbourne, Victoria, Australia.
- Department of Musculoskeletal Oncology, Rizzoli Orthopaedic Institute, Bologna, Italy.
- Department of Pathology, Sarcoma Unit, St Vincent's Hospital, Melbourne, Victoria, Australia.
- Department of Biostatistics, Burnet Institute of Medical Research, Melbourne, Victoria, Australia.
- Genesis Care, Radiation Oncology, St Vincent's Hospital, Melbourne, Victoria, Australia.
- Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia.
Cite
APA
Rhee, I., Spazzoli, B., Stevens, J., Hansa, A., Spelman, T., Pang, G., Guiney, M., Powell, G., Choong, P., & Di Bella, C. (2023). Oncologic outcomes in myxofibrosarcomas: the role of a multidisciplinary approach and surgical resection margins. ANZ Journal of Surgery, 93(3), 577-584. https://doi.org/10.1111/ans.18320
Vancouver
Rhee I, Spazzoli B, Stevens J, Hansa A, Spelman T, Pang G, et al. Oncologic outcomes in myxofibrosarcomas: the role of a multidisciplinary approach and surgical resection margins. ANZ Journal of Surgery. 2023;93(3):577-584. doi:10.1111/ans.18320
BibTeX
@article{Rhee2023,
author = {Rhee, Isaac and Spazzoli, Benedetta and Stevens, Jarrad and Hansa, Annjaleen and Spelman, Tim and Pang, Grant and Guiney, Michael and Powell, Gerard and Choong, Peter and Di Bella, Claudia},
title = {Oncologic outcomes in myxofibrosarcomas: the role of a multidisciplinary approach and surgical resection margins},
journal = {ANZ Journal of Surgery},
year = {2023},
volume = {93},
number = {3},
pages = {577--584},
doi = {10.1111/ans.18320}
}
EUVIMED